OPERF
KNSA icon

Oregon Public Employees Retirement Fund’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$149K Hold
2,324
– – ﹤0.01% 1491
2026
Q1 		$112K Hold
2,324
– – ﹤0.01% 1495
2025
Q4 		$95.9K Hold
2,324
– – ﹤0.01% 1502
2025
Q3 		$90.2K Buy
+2,324
New +$75.5K ﹤0.01% 1501

Other funds holding KNSA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Oregon Public Employees Retirement Fund's KNSA Position: Q2 2026 in Review

Oregon Public Employees Retirement Fund held its Kiniksa Pharmaceuticals (KNSA) position steady in Q2 2026 at 2,324 shares worth $149K. The position accounts for ﹤0.01% of the portfolio, ranked #1491.

Oregon Public Employees Retirement Fund first reported a position in KNSA in Q3 2025 and has held it in 4 quarters since. 94 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Oregon Public Employees Retirement Fund held 2,324 shares of Kiniksa Pharmaceuticals worth $149K as of Q2 2026.
  • Oregon Public Employees Retirement Fund left its Kiniksa Pharmaceuticals share count unchanged in Q2 2026.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Oregon Public Employees Retirement Fund's portfolio in Q2 2026, its #1491 holding.
  • Oregon Public Employees Retirement Fund first reported a position in Kiniksa Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 94 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.